In order to ensure the safety and effectiveness of medicines usage, “LIQVOR” has established and operates a system of pharmacovigilance, the main objective of which is to identify, study, evaluate and timely prevent adverse reactions, adverse events and other problems associated with the use of pharmaceutical preparations of the company, as well as to provide mandatory information to the competent government authorities. In order to monitor adverse reactions of drugs a special “report card” form is developed for the registration of adverse reactions in accordance with international requirements and recommendations.

*Personal information filled in the report is for internal use only and is not subject to publication.


Anna Bazeyan

responsible for the pharmacovigilance system